Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Public ClinicalTrials.gov record NCT02807636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) as Monotherapy and in Combination With Platinum-Based Chemotherapy in Patients With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase III, randomised study of atezolizumab alone and in combination with chemotherapy versus chemotherapy alone in participants with untreated advanced urothelial cancer.
Study identification
- NCT ID
- NCT02807636
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,213 participants
Conditions and interventions
Conditions
Interventions
- Atezolizumab Drug
- Carboplatin Drug
- Gemcitabine Drug
- Placebo Other
- Cisplatin Drug
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016 (Actual)
- Primary completion
- Aug 31, 2022 (Actual)
- Completion
- Feb 12, 2024 (Actual)
- Last update posted
- Feb 24, 2025
2016 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group | Rogers | Arkansas | 72758 | — |
| Coastal Integrative Cancer Care | San Luis Obispo | California | 93401 | — |
| Yale School of Medicine | New Haven | Connecticut | 06520-8032 | — |
| Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Christina Care Institutional Review Board | Newark | Delaware | 19713 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | — |
| UF Health Cancer Center at Orlando Health | Orlando | Florida | 32824 | — |
| Florida Cancer Specialists (St. Petersburg ? St. Anthony?s Professional Building) | St. Petersburg | Florida | 33705 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Parkview Research Center | Fort Wayne | Indiana | 46845 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40402 | — |
| East Jefferson Hematology Oncology | Metairie | Louisiana | 70006 | — |
| Park Nicollet Clin-Cancer Ctr | Saint Louis Park | Minnesota | 55426 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89148 | — |
| Mount Sinai School of Medicine - Tisch Cancer Institute | New York | New York | 10029 | — |
| University of North Carolina, Lineberger Cancer Ctr | Chapel Hill | North Carolina | 27599 | — |
| Bon Secours - St. Francis Hospital | Greenville | South Carolina | 29607 | — |
| Sarah Cannon Research Institute / Tennessee Oncology | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 186 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02807636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2025 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02807636 live on ClinicalTrials.gov.